Table 1. Glioblastoma patient characteristics.
Parameter | Training set | Validation set | |
---|---|---|---|
STS (n = 10) |
LTS (n = 9) |
Continuous (n = 19) | |
Patient age | |||
Mean (range) | 59.6 (49.0–68.0) | 56.8 (37.0–72.0) | 55.8 (42.0–69.0) |
Overall survival (months) | |||
Mean (range) | 7 (5–9) | 21 (17–32) | 13 (5–21) |
Radiation | |||
Yes | 8 | 8 | 19 |
No | 1 | 1 | 0 |
Unknown | 1 | 0 | 0 |
Temozolomide | |||
Concomitant | 0 | 0 | 0 |
Adjuvant (at tumor relapse) | 0 | 4 | 1 |
Unknown | 0 | 0 | 0 |
Resection | |||
Partial | 4 | 5 | 11 |
Radical | 4 | 3 | 5 |
Unknown | 2 | 1 | 3 |
Tumor tissue (%) | |||
Mean (range) | 77.0 (60.0–100.0) | 82.8 (70.0–100.0) | 78.4 (60.0–100.0) |
Specimen age | |||
Mean (range) | 13.5 (8.4–19.7) | 12.4 (7.5–17.6) | 13.1 (7.1–20.5) |
Abbreviations: LTS: long-term survivors; STS short-time survivors